Best in Biotech 16 May 2024
Five orthobiologics companies leading the way in the field
Discover five of the top orthobiologics companies leading the way in the field, as the market is set to grow in the next few years.
surgery
- Latest Posts
News and Trends 31 Mar 2023
Destiny Pharma gel reduces nasal staph in surgery patients
Destiny Pharma has revealed data showing its drug reduced Staphylococcus aureus in the nasal passage of pre-op cardiac surgery patients. Destiny Pharma is a clinical stage biotechnology company focused on the development of novel medicines to prevent life threatening infections. The data was published in the journal Infection Control & Hospital Epidemiology. The paper was […]
News and Trends 21 Dec 2022
Stem cell plasters could revolutionize heart surgeries
Researchers at the University of Bristol in the U.K. funded by the British Heart Foundation (BHF) have developed ‘stem cell plasters’ to revolutionize the way surgeons treat children living with congenital heart disease, so they don’t need as many open-heart operations. Heart defects are the most common type of anomaly that develop before a baby […]
News and Trends 8 Dec 2022
Novadip bone healing trial yields positive results
Novadip Biosciences SA has announced positive data from its phase 1/2 clinical trial evaluating the safety and clinical activity of its investigational product, NVD-003. The study was on patients with severe bone non-union (BNU) of the lower limb following trauma. Novadip is a clinical-stage biopharmaceutical company developing a new class of regenerative tissue products to […]
News and Trends 29 Nov 2022
Biocomposites antibiotic carrier, STIMULAN, receives approval for use in Mexico
UK-based medical devices company, Biocomposites Ltd., has announced that antibiotic carrier STIMULAN has received a new broad-based approval for use in bone and soft tissue in Mexico. The approval, granted by COFEPRIS, the Mexican Regulatory Authority, authorizes the use of STIMULAN as a carrier of substances such as antibiotics that are chosen by the surgeon […]
News and Trends 8 Nov 2022
MedinCell’s partner AIC registers trial for drug for total knee replacement pain
A partner of MedinCell, Arthritis Innovation Corporation (AIC), has registered a phase 3 trial to look into an alternative drug to deal with pain after total knee replacement (TKR). Arthritis Innovation Corporation conducts and finances all development activities of the drug F14, or mdc-CWM, being trialed. It was registered with the safety and efficacy study […]
ADVERTISEMENT
ADVERTISEMENT
News and Trends 5 Oct 2022
New biotech company aims to bridge gap between stem cell research and athletic injuries
Andrews Medicine of Pensacola, Florida, and Celltex Therapeutics Corporation of Houston, Texas, are to form a new biotechnology company to bridge the divide between stem cell research and the current treatment of athletic injuries. The jointly owned company will operate under the name of Andrews Celltex Biologics. The new company will undertake the operation of […]
News and Trends 26 Sep 2022
Surge raises $2.6M in funding for technology and secures exclusive licensing agreement
Surge, a biotech and artificial intelligence innovator that produces technology to decode immune fingerprints, has received $2.6 million in funding. The technology accurately identifies patients at risk before surgery and enables physicians to quickly forecast the risk of postoperative complications. The funding round was co-led by HCVC, a global early-stage fund dedicated to high-potential […]
News and Trends 19 Sep 2022
FDA approves Heron Therapeutics’ post-op nausea and vomiting drug
Heron Therapeutics, Inc. says the U.S. Food and Drug Administration (FDA) has approved APONVIE (aprepitant) injectable emulsion, for intravenous use for the prevention of postoperative nausea and vomiting (PONV) in adults. Heron Therapeutics’ APONVIE is the first and only IV formulation of aprepitant for PONV prevention. Administered via a single 30-second IV injection, APONVIE reaches […]
News and Trends 13 Sep 2022
Results of phase 3 trial of injection for ovarian cancer imaging published
An injection for intraoperative imaging of folate receptor positive ovarian cancer can identify more of the disease than is unable to be identified conventionally. Biotech company On Target Laboratories announced that the results from its phase 3, 006 study of the Cytalux (pafolacianine) injection had been published in the Journal of Clinical Oncology yesterday (September […]
ADVERTISEMENT